The Journal of Clinical Psychiatry The Journal of Clinical Psychiatry

The Journal of
Clinical Psychiatry

Empowering mental health professionals with peer-reviewed psychiatric research and insights

Back to top Open menu arrow
Current Issue Archives Authors Reviewers

Page 145

More JCP Articles

JCP
Commentary

May 25, 2016

JCP
Article

May 25, 2016

One alpha-1 noradrenergic antagonist drug has shown promise in treating PTSD-related sleep disturbances and nightmares, but it has a short half-life. Could the long half-life version of this type…
, , , et al
JCP
Original Research

May 25, 2016

What is the best method to pull acute PTSD patients from the depths of their anguish? This trial tested cognitive and prolonged-exposure therapy and SSRI treatment over 12 weeks….
, , , et al
JCP
Letter to the Editor

May 25, 2016

For some treatment-resistant patients with OCD, deep brain stimulation (DBS) is a viable option when pharmacotherapy doesn’ t help. The case study of Mr A explains how electroconvulsive therapy…
, , , et al
JCP
Original Research

May 25, 2016

, , , et al
JCP
Letter to the Editor

May 25, 2016

A number of studies have confirmed the xMHC region on human chromosome 6 to be associated with schizophrenia. Here, Dr Sun discusses her work on identifying schizophrenia candidate genes.
, , , et al
JCP
Book Review

May 25, 2016

JCP
Commentary

May 25, 2016

JCP
Article

May 25, 2016

Read 4 articles on comorbid PTSD on the phenotype of bipolar disorder, PTSD symptoms and the impact of depression on cognition and functioning after stroke.
JCP
Original Research

May 25, 2016

, , , et al
JCP
Commentary

May 25, 2016

JCP
Letter to the Editor

May 25, 2016

Ketamine may reduce OCD symptoms in some patients, but IV administration is undesirable. Learn whether oral memantine, another NMDA receptor antagonist, would be a good alternative.
, , , et al

Watch the New PsychCase360

Explore two real-world schizophrenia cases

Subscribe to read
more articles

Subscribe